Defective phosphorylation of interleukin‐18 receptor β causes impaired natural killer cell function in systemic‐onset juvenile idiopathic arthritis

W de Jager, SJ Vastert, JM Beekman… - Arthritis & …, 2009 - Wiley Online Library
W de Jager, SJ Vastert, JM Beekman, NM Wulffraat, W Kuis, PJ Coffer, BJ Prakken
Arthritis & Rheumatism, 2009Wiley Online Library
Objective Systemic‐onset juvenile idiopathic arthritis (JIA) is an autoimmune disease
characterized by arthritis and systemic features. Its pathogenesis is still largely unknown. It is
characterized immunologically by natural killer (NK) cell dysfunction and cytokine signatures
that predominantly feature interleukin‐1 (IL‐1), IL‐6, and IL‐18. Since IL‐18 can drive NK
cell function, we examined how the high plasma levels of this cytokine are related to the
documented NK cell failure in these patients. Methods The phenotype and function of NK …
Objective
Systemic‐onset juvenile idiopathic arthritis (JIA) is an autoimmune disease characterized by arthritis and systemic features. Its pathogenesis is still largely unknown. It is characterized immunologically by natural killer (NK) cell dysfunction and cytokine signatures that predominantly feature interleukin‐1 (IL‐1), IL‐6, and IL‐18. Since IL‐18 can drive NK cell function, we examined how the high plasma levels of this cytokine are related to the documented NK cell failure in these patients.
Methods
The phenotype and function of NK cells from 10 healthy control subjects, 15 patients with polyarticular JIA, and 15 patients with systemic‐onset JIA were characterized by staining and functional assays in vitro. IL‐18 ligand binding was visualized by fluorescence microscopy. Phosphorylation of several MAP kinases and the IL‐18 receptor β (IL‐18Rβ) were visualized by Western blotting.
Results
IL‐18 from the plasma of systemic‐onset JIA patients stimulated the activation of NK cells from healthy controls and bound its cognate receptor. However, NK cells from systemic‐onset JIA patients failed to up‐regulate cell‐mediated killing molecules, such as perforin and interferon‐γ, after IL‐18 stimulation. Furthermore, treatment with IL‐18 did not induce the phosphorylation of receptor‐activated MAP kinases in NK cells. Alternate activation of NK cells by IL‐12 induced NK cell cytotoxicity. We observed no additive effect of IL‐18 in combination with IL‐12 in systemic‐onset JIA patients. Immunoprecipitation of IL‐18Rβ showed that NK cells from systemic‐onset JIA could not phosphorylate this receptor after IL‐18 stimulation.
Conclusion
The mechanism of the impaired NK cell function in systemic‐onset JIA involves a defect in IL‐18Rβ phosphorylation. This observation has major implications for the understanding and, ultimately, the treatment of systemic‐onset JIA.
Wiley Online Library